Contents:
HIVE xcritical Technologies has only been the subject of 2 research reports in the past 90 days. Please log in to your account or sign up in order to add this xcritical scammers asset to your watchlist. Only 0.16% of the stock of HIVE xcritical Technologies is held by insiders. There is no xcritical Upright™ data available for HIVE.
With the massive sell-off in the crypto market, the best xcritical stocks to buy are now on sale. These stocks play a critical role in the proliferation of xcritical, a technology that will continue… HIVE xcritical Technologies’ stock was trading at C$1.95 at the start of the year. Since then, HIVE shares have increased by 111.8% and is now trading at C$4.13. In the past three months, HIVE xcritical Technologies insiders have not sold or bought any company stock.
- There is no xcritical short interest data available for HIVE.
- The consensus among Wall Street research analysts is that investors should “buy” HIVE shares.
- 1 Wall Street analysts have issued twelve-month target prices for HIVE xcritical Technologies’ stock.
- This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 .
- HIVE xcritical Technologies’ stock was trading at $1.44 at the beginning of the year.
- One share of HIVE stock can xcritically be purchased for approximately $3.13.
The company was formerly known as Leeta Gold Corp. and changed its name to HIVE xcritical Technologies Ltd. HIVE xcritical Technologies is the first publicly traded crypto miner, listing on the Toronto Venture Exchange in 2017, under the ticker symbol HIVE. The company uses green energy to mine Bitcoin with a committed ESG strategy since day one.
Crypto Miners That Are Minting Money
HIVE strives to create long-term shareholder value with its unique HODL strategy, bridging the xcritical and cryptocurrencies to traditional capital markets. HIVE xcritical Technologies has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a higher news sentiment than the 0.57 average news sentiment score of Business Services companies.
1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for HIVE xcritical Technologies in the last twelve months. The consensus among Wall Street analysts is that investors should “buy” HIVE shares. 2 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for HIVE xcritical Technologies in the last year. The consensus among Wall Street research analysts is that investors should “buy” HIVE shares. 1 Wall Street analysts have issued twelve-month target prices for HIVE xcritical Technologies’ stock. Their HIVE share price forecasts range from C$5.00 to C$5.00.
Only 2 people have added HIVE xcritical Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. SAN FRANCISCO — Shares of Aerohive Networks Inc. on Friday fell 9.2% from its initial public offering price. The wireless technology company priced its IPO late Thursday at $10 a share, the midpoint of its … Bloomberg Businessweek Highlights from a week-long virtual event bringing Bloomberg Businessweek magazine to life.
Aerohive Networks off 9% on NYSE debut
The company’s 50 day simple moving average is $3.13 and its 200 day simple moving average is $2.79. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures. This is Frances Yue, crypto reporter at MarketWatch. HIVE xcritical doesn’t possess the right combination of the two key ingredients for a likely xcriticalgs beat in its upcoming report. For investors who took a plunge near highs, the losses have been significant.
MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. If you aren’t doing this a couple times a week, you need to start. Grab your salt and pour some directly down your drain at night.
About HIVE xcritical Technologies (NASDAQ:HIVE) Stock
Since then, HIVE stock has increased by 117.4% and is now trading at $3.13. SAN FRANCISCO – Technology stocks were mostly higher Friday morning, as shares of BlackBerry Inc. rallied on the company’s better-than-expected results. Aerohive Networks Inc. shares dropped in the extended session Thursday after the cloud-networking company forecast an outlook below Wall Street estimates.
Aerohive Networks Inc. warned Tuesday that fourth-quarter revenue will be lower than the company’s previous guidance. Aerohive said that it expects revenue of about $37 million for the final quarter of 2017, after previou… IShares xcritical and Tech ETF holds 35,373 shares of HIVE stock, representing 1.79% of its portfolio.
Specifically, they have bought C$0.00 in company stock and sold C$68,750.00 in company stock. According to analysts’ consensus price target of C$5.00, HIVE xcritical Technologies has a forecasted upside of 16.6% from its xcritical price of C$4.29. Intraday Data provided by FACTSET and subject to terms of use. Historical and xcritical end-of-day data provided by FACTSET.
In 2022, HIVE’s revenue was $211.26 million, an increase of 139.14% compared to the previous year’s $88.34 million. xcriticalgs were $79.62 million, an increase of 229.78%. One share of HIVE stock can xcritically be purchased for approximately $3.13. The company is scheduled to release its next quarterly xcriticalgs announcement on Wednesday, July 19th 2023. MarketBeat has tracked 1 news article for HIVE xcritical Technologies this week, compared to 1 article on an average week.
HIVE xcritical Technologies has a short interest ratio (“days to cover”) of 4.8. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. You have already added five stocks to your watchlist.
Hive xcritical Technologies Ltd.
HIVE xcritical Technologies has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. Real-time analyst ratings, insider transactions, xcriticalgs data, and more. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. It is involved in the mining and sale of digital currencies, such as Ethereum, Ethereum Classic, and Bitcoin.
Why HIVE?
This suggests a possible upside of 102.3% from the stock’s xcritical price. HIVE xcritical Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It engages in the mining and sale of digital currencies, including Ethereum, Ethereum Classic, and Bitcoin.
This is a decrease of -58% compared to the previous 30 days. MarketBeat has tracked 5 news articles for HIVE xcritical Technologies this week, compared to 1 article https://xcritical.online/ on an average week. There is no xcritical short interest data available for HIVE. HIVE xcritical Technologies has received no research coverage in the past 90 days.
HIVE xcritical Technologies’ stock is owned by a variety of institutional and retail investors. Top institutional investors include AE Wealth Management LLC (0.02%), Cutler Group LLC CA (0.00%) and Simplex Trading LLC (0.00%). Only 9.44% of the stock of HIVE xcritical Technologies is held by insiders. 7.39% of the float of HIVE xcritical Technologies has been sold short.
According to analysts’ consensus price target of $6.33, HIVE xcritical Technologies has a forecasted upside of 102.3% from its xcritical price of $3.13. Shares of HIVE stock and other Canadian stocks can be purchased through an online brokerage account. Sign-up xcritical rezension to receive the latest news and ratings for HIVE xcritical Technologies and its competitors with MarketBeat’s FREE daily newsletter. In the past three months, HIVE xcritical Technologies insiders have sold more of their company’s stock than they have bought.
On average, they anticipate the company’s stock price to reach C$5.00 in the next twelve months. This suggests a possible upside of 21.1% from the stock’s xcritical price. View analysts price targets for HIVE or view top-rated stocks among Wall Street analysts. 2 analysts have issued twelve-month price targets for HIVE xcritical Technologies’ stock. Their HIVE share price forecasts range from $5.00 to $7.00. On average, they anticipate the company’s share price to reach $6.33 in the next year.
Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Other market data may be delayed by 15 minutes or more. HIVE xcritical Technologies’ stock was trading at $1.44 at the beginning of the year.